Literature DB >> 12409573

Gadolinium-enhanced MR imaging of the liver: optimizing imaging delay for hepatic arterial and portal venous phases--a prospective randomized study in patients with chronic liver damage.

Masayuki Kanematsu1, Richard C Semelka, Masayuki Matsuo, Hiroshi Kondo, Mayumi Enya, Satoshi Goshima, Noriyuki Moriyama, Hiroaki Hoshi.   

Abstract

PURPOSE: To investigate the optimal imaging delays for hepatic arterial and portal venous phases of gadolinium-enhanced dynamic spoiled gradient-recalled-echo magnetic resonance (MR) imaging of the liver in patients with chronic liver damage.
MATERIALS AND METHODS: MR images were obtained after intravenous bolus injection of gadopentetate dimeglumine in 100 patients with chronic liver damage. Test bolus imaging was performed to determine the aortic transit time. A 26-second spoiled gradient-recalled-echo sequence was used. Patients were randomized into four groups so that the middle of k space was acquired at 5, 10, 15, and 20 seconds for the first phase and 45, 50, 55, and 60 seconds for the second phase, respectively, from the time of arrival of contrast material in the abdominal aorta. Mean signal intensities of the liver, spleen, and abdominal aorta were measured, and images were reviewed prospectively by three radiologists in consensus. Analysis of variance, the Scheffé criterion for continuous data, and the Kruskal-Wallis test for categorical data were used for statistical evaluation.
RESULTS: Intense splenic enhancement with the moiré pattern without intense hepatic enhancement occurred at 10-15 seconds. Aortic and splenic enhancement significantly decreased from 45 to 50 seconds (P <.05). Spleen-to-liver contrast-to-noise ratio began to decrease at 20 seconds and decreased constantly over time. Qualitative results correlated well with quantitative results.
CONCLUSION: Biphasic imaging with k space centered at 10-15 and 50 seconds or later after arrival of contrast material in the abdominal aorta may be the optimal technique to obtain ideal contrast enhancement. Empirically, delays of 28-34 and 68 seconds or later after initiating contrast material injection may be effective for biphasic imaging. Copyright RSNA, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409573     DOI: 10.1148/radiol.2252010852

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Characterisation of small hypoattenuating hepatic lesions in multi-detector CT (MDCT) in patients with underlying extrahepatic malignancy: added value of contrast-enhanced MR images.

Authors:  Song-Ee Baek; Mi-Suk Park; Hye Sook Hong; Jin Young Choi; Yong Eun Chung; Joon Seok Lim; Myeong-Jin Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2010-07-09       Impact factor: 5.315

2.  Application of direct virtual coil to dynamic contrast-enhanced MRI and MR angiography with data-driven parallel imaging.

Authors:  Kang Wang; Philip J Beatty; Scott K Nagle; Scott B Reeder; James H Holmes; Mahdi S Rahimi; Laura C Bell; Frank R Korosec; Jean H Brittain
Journal:  Magn Reson Med       Date:  2014-02       Impact factor: 4.668

3.  Dynamic contrast-enhanced MR imaging of endometrial cancer: optimizing the imaging delay for tumour-myometrium contrast.

Authors:  Sung Bin Park; Min Hoan Moon; Chang Kyu Sung; Sohee Oh; Young Ho Lee
Journal:  Eur Radiol       Date:  2014-07-24       Impact factor: 5.315

4.  Test bolus measurement: effects of the respiratory position on bolus arrival time and signal-intensity-time curve quality.

Authors:  Rolf Janka; Marius Rudy; Rudy Marius; Michael Lell; Lell Michael; Michael Uder; Uder Michael; Werner Bautz; Bautz Werner; Evelyn Wenkel; Wenkel Evelyn
Journal:  MAGMA       Date:  2007-09-05       Impact factor: 2.310

5.  Comparison of the Timing of Hepatic Arterial Phase and Image Quality Using Test-Bolus and Bolus-Tracking Techniques in Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced Hepatic Dynamic Magnetic Resonance Imaging.

Authors:  Yuji Iyama; Takeshi Nakaura; Koichi Yokoyama; Masafumi Kidoh; Daisuke Utsunomiya; Seitaro Oda; Tomohiro Namimoto; Yasuyuki Yamashita
Journal:  J Comput Assist Tomogr       Date:  2017 Jul/Aug       Impact factor: 1.826

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.